David A. Siegel Haemonetics Corp Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Haemonetics Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 46,755 shares of HAE stock, worth $3.76 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,755
Previous 62,555
25.26%
Holding current value
$3.76 Million
Previous $5.34 Million
27.55%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$556 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$479 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$413 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$308 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$308 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.12B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...